Fresno

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Liver cirrhosis1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Akero Therapeutics, Inc2 trials

Closed trials

• Completed

  A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

  NCT05039450· Phase 2· Akero Therapeutics, Inc· Source

• Completed

  A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

  NCT04767529· Phase 2· Akero Therapeutics, Inc· Source